Announced Thu, 16 Oct · 17:30 IST

Meeting updates of Board Meeting scheduled to be heled on 16th October, 2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Asston Pharmaceuticals' Board of Directors met on 16th October 2025 and approved several key items. The company appointed CA Yash Jain's firm as its internal auditor for FY 2025-26, Mr. Yogesh Supekar as Additional Non-Executive Non-Independent Director, and Mr. Rishi Upadhaya as Company Secretary and Compliance Officer (Key Managerial Personnel). Additionally, the Board approved raising up to Rs. 3 crore as an interest-free unsecured loan from its directors (to be drawn in lump sum or tranches). The Board also approved a secured loan facility of up to Rs. 2.70 crore from HDFC Bank, Sector-11 CBD Belapur branch, for purchasing a commercial space, with the property itself serving as security.

Likely market impact

Multiple governance additions strengthen the company's leadership team, while the Rs. 2.70 crore HDFC Bank loan signals investment in commercial property. The Rs. 3 crore interest-free director loan reflects promoter confidence without straining the balance sheet with interest costs.